Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRX·NASDAQ

$22.32

+0.31%
HealthcareDrug Manufacturers - Specialty & Generic

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$877.96M
EPS0.1600
P/E Ratio139.50
Earnings Date08/04/2026

pcrx

Selling, General and Administrative Expenses

Last Annual Value

368.76M

3-Year CAGR

13%

5-Year CAGR

14%

10-Year CAGR

10%

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Competitors Analysis of Selling, General and Administrative Expenses

PCRX · NASDAQ
CompanySelling, General and Administrative Expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
368.76M
11.0%13.1%9.2% 
279.72M
33.4%35.1%N/A
434.13M
7.2%10.7%18.0%
ANAB logo
AnaptysBio, Inc.
NASDAQ:ANAB
50.74M
6.5%18.7%28.0%
52.02M
-9.9%4.9%32.6%
XNCR logo
Xencor, Inc.
NASDAQ:XNCR
63.64M
6.0%10.4%17.1%
155.10M
18.5%N/A37.5%
24.62M
42.6%255.5%N/A
Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Fair Value Envelope

PCRX · NASDAQ

Our analysis suggests that PCRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $22.32, this represents a potential HIDDEN relative to our calculated worth for Pacira BioSciences, Inc..

Intrinsic Value
Current Price: $22.32